A Preliminary Study on Human Placental Tissue Impaired by Gestational Diabetes: A Comparison of Gel-Based versus Gel-Free Proteomics Approaches
Abstract
Gestational diabetes (GDM) is the most common complication of pregnancy and it is associated with maternal and fetal short- and long-term consequences. GDM modifies placental structure and function, but many of the underlying mechanisms are still unclear. The aim of this study is to develop and compare two different methods, based respectively on gel-based and gel-free proteomics, in order to investigate the placental proteome in the absence or in the presence of GDM and to identify, through a comparative approach, possible changes in protein expression due to the GDM condition. Placenta homogenates obtained by pooling six control samples and six samples from GDM pregnant women were analyzed by two-dimensional (2D) electrophoresis coupled with mass spectrometry [nano-liquid chromatography (nano-LC) tandem mass spectrometry (MS/MS) and matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS)] and by a label-free mass spectrometry method based on LC-MS E . The gel-based approach highlights 13 over-expressed proteins and 16 under-expressed proteins, while the label-free method shows the over-expression of 10 proteins and the under-expression of nine proteins. As regards 2D gel electrophoresis, a comparison between two different protein identification methods, based respectively on nLC-electrospray ionization-MS/MS and MALDI-MS/MS, was performed taking into consideration the sequence coverage, the MASCOT score and the exponentially modified protein abundance index. The analysis of the complex proteome through an integrated strategy revealed that the quantitative gel-free and label-free MS approach might be suitable to identify candidate markers of GDM.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Studies of the placental proteome have identified differences in the expression of proteins between GDM and non-GDM placentas.
“Similarly, studies of the placental proteome have identified differences in the expression of proteins between GDM and non-GDM placentas [155].”
From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [155]
Cites
Absolute Quantification of Proteins by LCMSE
Silva, J. C., Gorenstein, M. V., Li, G.-Z., Vissers, J. P. C., & Geromanos, S. J. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500230-mcp200 · Cited by 1,529 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The Pathophysiology of Gestational Diabetes Mellitus
Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113342 · Cited by 1,874 · see citing works
“Similarly, studies of the placental proteome have identified differences in the expression of proteins between GDM and non-GDM placentas [155].”
Background
- Authors
- Roverso, M., Brioschi, M., Banfi, C., Visentin, S., Burlina, S., Seraglia, R., Traldi, P., & Lapolla, A.
- Affiliations
- University of Padua (IT)
- Centro Cardiologico Monzino (IT)
- Institute of Condensed Matter Chemistry and Technologies for Energy (IT)
- Corresponding author
- Roverso, Marco
- ORCID
- Venue
- European Journal of Mass Spectrometry
- Publisher
- SAGE Publications
- Published
- 2016-04
- Volume
- 22
- Issue
- 2
- Pages
- 71-82
- ISSN
- 1356-1049 (ISSN-L)
- 1469-0667
- 1751-6838
- OpenAlex
- W2344800550
- Cited by
- 37
- References
- 1
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 2 · 2022: 6 · 2021: 8 · 2020: 4 · 2019: 6 · 2018: 5 · 2017: 3
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Mass Spectrometry (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Università degli Studi di Padova
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- gestational diabetes mellitus, placenta, placental proteome, protein expression changes, gel-based proteomics, gel-free proteomics, label-free mass spectrometry, MALDI-MS/MS, nanoLC-MS/MS, two-dimensional gel electrophoresis, protein abundance quantification
- MeSH terms
- Female, Humans, Placenta, Pregnancy, Electrophoresis, Gel, Two-Dimensional, Diabetes, Gestational, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Proteome, Proteomics, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review